Direxion Daily S&P Biotech Bull 3X ETF (LABU)

NYSEARCA: LABU · Real-Time Price · USD
172.57
-17.78 (-9.34%)
May 15, 2026, 4:00 PM EDT - Market closed
Assets$503.90M
Expense Ratio0.96%
PE Ration/a
Shares Out2.92M
Dividend (ttm)$1.23
Dividend Yield0.71%
Ex-Dividend DateDec 23, 2025
Payout Frequencyn/a
Payout Ration/a
Volume748,935
Open183.84
Previous Close190.35
Day's Range170.73 - 184.49
52-Week Low44.69
52-Week High212.45
Beta2.50
Holdings168
Inception DateMay 28, 2015

About LABU

Fund Home Page

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is issued by Direxion.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol LABU
ETF Provider Direxion
Index Tracked S&P Biotechnology Select Industry

Top 10 Holdings

36.11% of assets
NameSymbolWeight
Goldman Finl Sq Trsry Inst 506n/a8.25%
Dreyfus Govt Cash Man Insn/a7.21%
S&P Biotechnology Select Industry Index Swapn/a5.33%
S&P Biotechnology Select Industry Index Swapn/a3.89%
S&P Biotechnology Select Industry Index Swapn/a2.78%
S&P Biotechnology Select Industry Index Swapn/a2.67%
Goldman Sachs Fin Gov 465 Institutn/a1.69%
S&P Biotechnology Select Industry Index Swapn/a1.56%
Apellis Pharmaceuticals, Inc.APLS1.43%
TG Therapeutics, Inc.TGTX1.32%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 23, 2025$0.90971Dec 31, 2025
Sep 23, 2025$0.10273Sep 30, 2025
Jun 24, 2025$0.21897Jul 1, 2025
Mar 25, 2025$0.10714Apr 1, 2025
Jun 25, 2024$0.15021Jul 2, 2024
Mar 19, 2024$0.16064Mar 26, 2024
Full Dividend History

Performance

LABU had a total return of 280.24% in the past year, including dividends. Since the fund's inception, the average annual return has been -22.94%.

News

Where to Buy Booming Biotech ETFs

Discover why biotech stocks are surging despite large fund outflows. Monitor these three industry ETFs for "buy the dip" opportunities.

Other symbols: PBEXBI
7 years ago - Investopedia

Jablonski: Biotech presents a good buying opportunity

Sylvia Jablonski of Direxion discusses why biotech stocks and ETFs are attractive right now, due to their cheapness relative to the rest of the market.

Other symbols: CUREXLV
7 years ago - CNBC Television

Biotech stocks fall after Trump promises executive order drug prices

CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.

7 years ago - CNBC Television